Navigation Links
CRH Medical Corporation announces substantial increase in patient visits
Date:2/5/2008

VANCOUVER, Feb. 5 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today for the year ended December 31, 2007, it had 13,461 patient visits at its Centers for Colorectal Health compared to 1,699 patient visits for the same period in 2006.

Commenting on this achievement, Edward Wright, CEO of CRH Medical Corporation stated, "In 2007, we demonstrated the strong demand for the CRH O'Regan hemorrhoid banding technology and treatment protocol. In 2008, we plan to open several additional Centers in new markets throughout the United States allowing CRH to further capitalize on this large and underserved market. According to the National Institutes of Health the prevalence rate of symptomatic hemorrhoids in the United States is approximately 4.4% of the population or 13.3 million people."

Centers open one year or longer continue to show strong growth, with patient visits increasing 485% for the three months ended December 31, 2007 compared to the same period in 2006.

Commenting on the CRH O'Regan Hemorrhoid Banding technology and treatment protocol, Dr. Iain Cleator, Chief Medical Director of CRH said, "The most important aspect of our technology and treatment protocol is that we are experiencing the same excellent results in each of our Centers. This means that our training methodology and treatment protocol is transferable and reproducible."

Dr. Carolyn Million, Medical Director of CRH's San Francisco Center, added, "As a Fellow of the American Society of Colon and Rectal Surgeons I have treated hemorrhoids for 15 years. In my opinion the CRH O'Regan banding technology and treatment protocol consistently provide a significantly higher level of patient satisfaction compared with other hemorrhoid treatments options."

About CRH Medical Corporation:

CRH Medical Corporation is utilizing the first single use, patented, disposable, hemorrhoid banding system through its Center for Colorectal Health facilities. According to the National Institute of Health approximately 50% of the U.S. population will develop hemorrhoids by age 50. CRH Medical is opening its Center for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening and plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market. The Company's goal is to become the preeminent resource on colorectal health for consumers and medical professionals in North America.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.

The TSX Venture Exchange does not accept responsibility for the adequacy

or accuracy of this release.

CONTACT: Dean Linden, Investor Relations, CRH Medical Corporation at (604) 633-1440, or ir@crhmedcorp.com; Additional information may also be found by visiting the Company's website at http://www.crhmedcorp.com, or the SEDAR website at http://www.sedar.com


'/>"/>
SOURCE CRH Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Phase II Medical Manufacturing Selects IQMS for ERP Solution
2. MAP Pharmaceuticals Announces Resignation of Chief Medical Officer
3. Presidents Proposed 2009 Medicare Budget Would Weaken Seniors Access to Durable Medical Equipment and Therapies Required in the Home
4. 7th Annual Wiley Prize in Biomedical Sciences Awarded to Dr. Richard P. Lifton
5. ATS Medical Expects Fourth Quarter Revenue to Increase by Approximately 32%
6. MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records
7. MCM Completes LAC+USC Replacement Medical Facility Project
8. MCM Completes Westwood Replacement Hospital - Ronald Reagan UCLA Medical Center
9. Medical Simulation Corporation and the American Board of Internal Medicine Introduce New Simulation for Physician Assessment and Evaluation
10. Globus Medical Announces Record Revenue for 2007
11. MedStar Health Unveils Rx for Success Program at Vivien T. Thomas Medical Arts Academy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), ... has filed a patent application directed to the treatment ... --> --> The new invention ... (histamine dihydrochloride) in combination with immune checkpoint inhibitors. The ... of Ceplene and IL-2 therapy in patients with Acute ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology: